#United States #Washington #Neurodiversity #Floreo #VR Therapy

Floreo’s Initiative for Neurodivergent Learners

In a significant move to enhance virtual reality (VR) therapy for individuals on the neurodiversity spectrum, Floreo has announced the establishment of its first scientific advisory board. This pioneering step aims to bring together leading experts from various fields to advance evidence-based therapeutic support for neurodivergent youth and adults.

Who We Are and What We Do

Floreo is at the forefront of developing VR-based therapeutic solutions targeted specifically at neurodiverse individuals, including those with Autism Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD), and other related conditions. The aim is not just to provide therapy but to empower users with essential life skills in an immersive, engaging manner. Floreo’s platform is designed for use in clinical and educational settings, offering immersive VR lessons that focus on key areas such as social interactions, behavioral management, communication, and emotional regulation.

The Formation of the Advisory Board

Chaired by Dr. Paula Pompa-Craven, a licensed clinical psychologist and chief clinical officer at Easterseals Southern California, the advisory board comprises six distinguished members with extensive backgrounds in behavioral health research and clinical practice. Dr. Pompa-Craven's rich experience since 1995 has placed her in a pivotal role in shaping therapy services for thousands of individuals.

Vijay Ravindran, CEO and founder of Floreo, emphasized the importance of collaboration across scientific, clinical, and technology sectors to ensure that Floreo's VR tools remain grounded in clinical rigor. According to Ravindran, this collaboration has the potential to yield groundbreaking approaches to supporting individuals living with autism.

Board Members and Their Contributions

The board's founding members include:

• - Dr. Elder Granger: A retired U.S. Army Major General and the current CEO of THE 5Ps, LLC. His career has included vital roles in ensuring quality health care for military personnel.
• - Dr. Rhonda Moore: A cultural and medical anthropologist focused on the lived experiences of individuals with disabilities, Dr. Moore brings insights from her extensive work with health and disability.
• - Anna Moznavsky: Senior Vice President of Clinical Operations at the Center for Social Dynamics, she focuses on enhancing clinical quality and education for behavioral health professionals.
• - Marsha Stepensky: Director of Therapy Content at Floreo, she specializes in creating evidence-based VR therapy lessons and has extensive experience in behavior analysis.
• - Shirley Mak-Parisi: With over 20 years in clinical research, Mak-Parisi ensures rigorous research methodologies and patient safety in the development of Floreo's therapeutic tools.

Pioneering Pathways in Neurodiversity Therapy

The newly formed scientific advisory board held its first meeting during the Association for Behavior Analysis International (ABAI) conference, where they began formulating strategies for research initiatives and clinical study designs. Floreo aims for these strategies to significantly enhance the scientific validation of its VR-based learning tools.

Furthermore, Floreo recently achieved a major milestone as the first VR autism technology to receive the FDA's breakthrough device designation, emphasizing its commitment to delivering effective tools for neurodiverse individuals.

Vision for the Future

Floreo envisions a future where every neurodiverse individual has access to open and supportive environments tailored for their success. By developing the behavioral therapy metaverse, Floreo intends to create secure virtual spaces where learners can cultivate meaningful skills applicable to their day-to-day lives. This innovative approach is poised to transform how intervention strategies are delivered, moving towards a more inclusive and accessible educational framework for all.

With this advisory board in position, Floreo is on a path towards not only enhancing its technology but also setting new standards in the treatment and support of neurodivergent individuals. To find out more about Floreo and its groundbreaking initiatives, visit floreovr.com.